Noteworthy - September 2024

September 30, 2024 Providence inScope Content Team

Media alerts:

Dr. Elisa Akagi gives an update on flu vaccine changes - KDRV, Medford

Dr. Liberato Mukul spoke about new research on hormone replacement therapy and what it means for menopausal women - KATU, Portland

Resources:

Providence Brain and Spine Institute's now offering a Neuro Oncology education series for patients and families

Creating close-to-home care at Providence Seaside (Link: Providence network only)

Events/CME:

Living with Melanoma Patient Symposium Features PCI Experts

Providence Cancer Institute – On Friday, Oct. 25, join AIM at Melanoma Foundation and Providence Cancer Institute for "Living with Melanoma Patient Symposium," a free, virtual event featuring the latest research and information on melanoma. Get practical tips and resources for managing melanoma and learn about the latest developments in melanoma research, including clinical trials, cellular therapy and emerging treatments.

A welcome and introduction to melanoma and clinical trials by Chris Fountain, RN, OCN, oncology clinician and researcher, Providence Cancer Institute, will be followed by:

Cellular Therapy for Melanoma: TIL the Future?
Brendan Curti, M.D., Medical Oncologist, Medical Director, Providence Melanoma Program, Providence Cancer Institute
Emerging Neoadjuvant and Adjuvant Therapies for Locally Advanced Melanoma
Matthew Taylor, M.D., Medical Oncologist, Co-Medical Director, Providence Melanoma Program, Providence Cancer Institute
Survivorship: Making Meaning
Noa Curtis, MSW, LCSW, Oncology Social Worker, Providence Cancer Institute
AIM at Melanoma Patient Resources
Ann Garst Taylor, Director of Community Engagement, AIM at Melanoma Foundation

The symposium concludes with a Q&A session.

Event details
Friday, Oct. 25, 2024
10:00 a.m. – Noon

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Noteworthy - September 2024

About the Author

Previous Article

Next Article

Noteworthy - September 2024

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).

The regional pharmacy team regularly updates its Pathway to Treat tool for providers, helping to guide evidence-based care.